{
    "nctId": "NCT05401942",
    "briefTitle": "Real-time Tele-monitoring Versus Routine Monitoring of Breast Cancer Patients Receiving Adjuvant Systemic Therapy",
    "officialTitle": "Real-time Tele-monitoring Versus Routine Monitoring of Breast Cancer Patients Receiving Adjuvant Systemic Therapy.",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer Female",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "Comparison of frequency and severity of symptoms using real-time tele-monitoring versus routine symptom monitoring.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Stage I-III breast cancer under adjuvant intravenous chemotherapy with or without targeted therapy.\n2. Able to provide a written informed consent .\n3. Must have an internet access.\n\nExclusion Criteria:\n\n1. Presence of other malignancies whether in the past or simultaneously.\n2. Male cancer patients.\n3. Clinical diagnosis of Alzheimer's disease.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}